Showing 61 - 70 of 113 for "Yi Wang" with applied filters
Banking and finance, Capital markets, Competition/antitrust, Construction, Corporate and M&A, Dispute resolution, Intellectual property, Investment funds, Labour and employment, Private equity, Regulatory, Restructuring and insolvency, Tax
Media and entertainment, Real estate
Banking and finance, Capital markets, Construction, Corporate and M&A, Dispute resolution, Intellectual property, Investment funds, Labour and employment, Pharmaceuticals and life sciences, Private equity, Regulatory, Restructuring and insolvency, Tax
Aviation and shipping, Pharmaceuticals and life sciences
Aviation and shipping, Banking and finance, Capital markets, Competition/antitrust, Construction, Corporate and M&A, Dispute resolution, Insurance, Intellectual property, Investment funds, Labour and employment, Private equity, Restructuring and insolvency, Shipping, Tax, Technology and telecommunications
Insurance
04 January 2024 by
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
15 September 2023 by
From January 2023 to now, AnJie Broad has recruited Mr. Keyu CAO, Mr. Zhining Wang, Mr. Mingqing Zhao, Mr. Kevin TSEN, Ms. Yolanda ZHANG, Ms. Yanyan DENG, Mr. Heng KUANG, Ms. Xueping WEI, Mr. Mark YANG, Mr. Min DING, to join the Firm as partners, and has also internally promoted Ms. Shanshan WU, Ms. Kaiying XU, Ms. Yue MA, Ms. Jingjing CAI, Mr. Xingchao HUANG, Mr. Danyang XIANG to become partners.
15 August 2023 by
A recent ruling rendered by Beijing Higher People’s Court of China, on granting the enforcement of the arbitral awards, has attracted much attention and discussion of the competition law circle.
16 May 2023 by
Recently, AnJie Broad Law Firm received a Consent Award signed by the international arbitrators, Mr. Philip Yang, Mr. Patrick O'Donovan, and Mr. Danny Mok, from the UK and Hong Kong
17 March 2022 by
Introduction With effect from 1 April 2022, Malaysia will enter the “Transition to Endemic” phase.
16 February 2022 by
Press Release
02 February 2021 by
The Greater Bay Area companies may choose to list in the A-shares market in Mainland China or Hong Kong. Small and medium-sized enterprises may also choose to list on GEM in Hong Kong which has relatively lower requirements for listing.
